Rocket Lab opened lower at $55.71, compared with its previous close of $59.10. In the last trading session, the stock traded between $54.49 and $57.55. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Rocket Lab is now worth
$ 388.58
giving a profit of
$ 288.58 (288.58%)
Note: Past profits do not guarantee future returns.
Rating from 18 Analysts
Today's Change
$-4.51 (-7.62%)
Day High
$57.55
Day Low
$54.49
Day Open
$55.71
Prev Close
$59.10
Volume
77,33,839
1W Return
6.56%
1M Return
-21.67%
3M Return
-6.81%
6M Return
-29.12%
1Y Return
-17.48%
Market Cap ($ Mn)
32,673
PE Ratio
-
PB Ratio
11.78
PEG Ratio
-
ROE
-22.00%
ROCE
-16.72%
EPS (TTM)
$-0.08
1 Week
6.56%
1 Month
-21.67%
3 Months
-6.81%
6 Months
-29.12%
9 Months
-36.28%
Rocket Lab shares deliver 32% annualized return over five years
Rocket Lab shares achieved a 32.34% average annual return over the last five years. A $100 investment from five years ago is now valued at $413.16. The stock outperformed the market by 21.21% on an annualized basis. Current market capitalization stands at $32.84 billion with a share price of $54.11.
8 days agoRocket Lab stock rises 4.4% as SpaceX posts strong Q3 results
Rocket Lab shares rose 4.44% to $53.16 on Wednesday. SpaceX reported Q3 revenue of $14.58 billion, up 161% YoY. Rocket Lab built the Viasat Maxwell spacecraft launched Tuesday. Analysts expect Rocket Lab to report a loss of seven cents per share on November 9.
8 days agoRocket Lab Corporation Q3FY26 Results: Stock up 3% on earnings date
Rocket Lab shares rose 3.04% to $52.45 after announcing Q3FY26 earnings date. Q3FY26 results scheduled for November 9, 2026, after market close. Previous quarter revenue of $234.07 million beat estimates by 1.30%. Cantor Fitzgerald maintains Overweight rating with $122 price target.
9 days agoRocket Lab shares rise as Cantor maintains $122 target despite delay
Rocket Lab shares rose 3.34% to $52.54 on Monday. Cantor Fitzgerald maintained Overweight rating with $122 price target. Neutron rocket debut delayed to second quarter of 2027 due to production issues. Pending Iridium acquisition valued at $8 billion enterprise value. Analysts expect combined revenue to roughly double post-acquisition.
11 days agoRocket Lab stock falls 11.2% as Neutron launch delayed to 2027
Rocket Lab delayed Neutron inaugural launch to 2027 due to carbon fiber defects in the propellant dome. Stock fell 11.22% to $52.54 following the announcement of the schedule slip. Q2 revenue hit a record $234 million, up 62% YoY, with backlog surging 137% to $2.36 billion. Recent defense awards totaling over $650 million are not yet reflected in the current backlog figure. Neutron remains unproven while contributing zero revenue, highlighting dependency on future execution.
15 days agoRocket Lab shares rise as NASA nears bulk launch purchase for moon base
Rocket Lab shares rose 3.59% to $75.64 on Tuesday. NASA plans bulk rocket purchases for its $30 billion moon base project. Agency aims to address supply bottlenecks by buying multiple rocket types. Rocket Lab's Neutron is positioned as an alternative to SpaceX's Falcon 9.
24 days ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $143.89 | -0.92% | $11,63,434.54M | - | |
| $313.05 | +3.96% | $3,23,490.84M | 40.40 | |
| $199.40 | +1.82% | $2,69,078.54M | 37.27 | |
| $643.59 | +2.20% | $1,48,672.51M | 20.78 | |
| $172.65 | +3.30% | $1,36,816.49M | 74.94 | |
| $370.82 | +4.65% | $1,00,327.95M | 23.14 | |
| $205.94 | +5.51% | $82,129.08M | 57.08 | |
| $562.36 | +1.73% | $79,891.11M | 17.34 | |
| $1,175.91 | +3.46% | $65,000.78M | 35.97 | |
| $278.43 | +6.84% | $51,847.84M | 26.49 | |
| $160.04 | -9.60% | $50,737.80M | 49.49 | |
| $807.41 | +3.61% | $37,825.54M | 53.41 |
An investment of $100 made 5 years ago in Rocket Lab is now worth
$ 388.58
giving a profit of
$ 288.58 (288.58%)
Note: Past profits do not guarantee future returns.
